L26/P-305 The effect of transportation of vitrified donor oocytes on recipient outcomes: a retrospective analysis on 2467 donor oocyte recipient cycles
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von G. Woodhead und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does the transport of vitrified donor oocytes affect rates of survival, fertilisation, blastocyst, utilisation, positive hCG tests and clinical pregnancy in recipient cycles? Summary answer All rates were comparable and showed no significant differences following Chi squared analysis. What is known already The implementation of oocyte vitrification has facilitated higher survival rates, leading to the feasibility of long term storage for fertility preservation and donor banks. Donor banks transport vitrified oocytes to receiving clinics using liquid nitrogen (LN2) vapour shippers, which maintains temperature at -185 °C. The hypothetical risks of transportation include mechanical stress and devitrification and recrystallisation if the temperature is not maintained. Limited literature is available regarding the effect of transportation of gametes and embryos. However, one study by Parmagiani et al (2017) reported a 20% decrease in survival rates when donor oocytes were shipped via plane compared with road couriers. Study design, size, duration This retrospective analysis was performed on 5 and a half years data ranging from the 1st of January 2020 to the 1st of July 2025. 2,467 warmed donor oocyte recipient cycles were analysed. Participants/materials, setting, methods Treatment cycle data was extracted from the clinic database, compiled onto an Excel spreadsheet and ran through Power Query for data transformation and cleaning. Donor codes contain a three letter prefix which denotes the clinic location they registered at. If this location differed from the recipient cycle location, then the oocytes were considered to be transported. Patient and donor ages were analysed using t-test, whereas rates were analysed via Chi squared analysis (Python, scipy). Main results and the role of chance From the 146,919 treatment cycles extracted, 2,467 recipient cycles utilised vitrified donor oocytes. 2098 of these cycles utilised transported oocytes and 369 cycles utilised non-transported oocytes. 18,766 oocytes were warmed in total, 15,973 and 2,793 for the transported and non-transported groups respectively. The survival rates were 83.1% and 84.5% respectively (p > 0.05). Fertilisation rates were similar at 73.3% and 74.1% respectively (p > 0.05). Blastocyst rates were also comparable at 64.2% and 64.0% respectively (p > 0.05). Utilisation rates were 45.9% and 45.4% respectively (p > 0.05). Positive hCG test rates were slightly higher for non-transported oocytes at 56.7% and 62.3% respectively, however, this was not statistically significant (p > 0.05). Clinical pregnancy rates were also higher for non-transported oocytes at 43.9% and 49.2% respectively, again showing no significance (p > 0.05). There were no significant differences in the average recipient age (p > 0.05) which were 41.4 and 41.8 years of age respectively. The average donor ages were significantly different (p < 0.05) between the two groups, 28.0 vs 28.7 years of age respectively, however, due to donation criteria, this would not be considered to have a clinical effect on recipient outcomes. Limitations, reasons for caution Due to the large number of cycles, each cycle could not be checked. Therefore, the assumption of the donor code prefix indicating the donor’s treatment clinic could be incorrect for a very low number of cases. However, due to the number of cycles, this risk is mitigated. Wider implications of the findings This study supports the use of vapour phase shipment to supply donor oocytes to recipient clinics via road transportation. Trial registration number No
Zitieren
APA
Woodhead, G., Barnikel, Z., & Campbell, A. (2026). L26/P-305 The effect of transportation of vitrified donor oocytes on recipient outcomes: a retrospective analysis on 2467 donor oocyte recipient cycles. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.641
Vancouver
Woodhead G, Barnikel Z, Campbell A. L26/P-305 The effect of transportation of vitrified donor oocytes on recipient outcomes: a retrospective analysis on 2467 donor oocyte recipient cycles. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.641
BibTeX
@article{Woodhead2026,
author = {Woodhead, G. and Barnikel, Z. and Campbell, A.},
title = {L26/P-305 The effect of transportation of vitrified donor oocytes on recipient outcomes: a retrospective analysis on 2467 donor oocyte recipient cycles},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.641}
}
EUVIMED